Eosinophil-mast cell interaction: Mepolizumab leads to a reduction of clinical symptoms and serum tryptase in a patient with eosinophilic asthma and idiopathic mast cell activation

Details

Language :

English

ISSN :

22132198

Volume :

9

Issue :

3

Database :

Supplemental Index

Journal :

The Journal of Allergy and Clinical Immunology: In Practice

Publication Type :

Periodical

Accession number :

ejs54446824

Full Text :

https://doi.org/10.1016/j.jaip.2020.10.020